Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Agencourt To Provide SNP Services For Duke

NEW YORK, May 13-Agencourt Bioscience will provide SNP genotyping services and develop pharmacogenomic markers for the Duke University Medical Center Department of Anesthesiology, the company said today.


The research program will probe the causes of post-surgical organ dysfunction.  Agencourt will use its Sequenom mass spectrometry genotyping platform and its own genomic services capabilities to identify potential new therapeutic targets.


Agencourt and Duke did not divulge rights or financial details, and did not say how many samples would be processed through this arrangement.


"More and more of these [genotyping] studies are coming about," said Agencourt vice president and chief scientific officer Kevin McKernan. "More hospitals are having these studies lined up than biotech."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more